NCT00819754 - A Phase I/II Study of IXO With Bevacizumab in Patients With Metastatic Colorectal Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

February 29, 2012

Study Completion Date

May 31, 2012

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG

IXO regimen + bevacizumab

"Phase I study - identifies the safety of IXO with bevacizumab and recommended phase II dose~Phase II study - assesses efficacy and safety of IXO with bevacizumab"

Trial Locations (1)

K1H 8L6

The Ottawa Hospital Cancer Centre, Ottawa